Can this report be signed electronically?

Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, provided intent, consent, attribution, and retention are satisfied.

When is a stronger authentication method required?

Use stronger authentication (SMS OTP, KBA, or vendor MFA) when PHI or regulatory risk is high, or when sponsor/IRB contractually requires elevated signer assurance.

Does HIPAA permit eSignature and cloud storage?

Yes, with safeguards. Covered entities must ensure vendor BAAs, encryption (TLS in transit, AES-256 at rest), access controls, and breach protocols are in place.

Are digital (PKI) signatures required?

Not always. PKI/digital signatures provide stronger non-repudiation and may be required by 21 CFR Part 11 for FDA-regulated electronic records.

How do I fix a post-signature error?

Prepare a signed amendment or corrected addendum, include rationale and approvals, and retain both original and correction with audit trail for transparency.

What records should be retained for audits?

Keep the final report, source documents, consent forms, audit logs, and signatory evidence. Follow HIPAA (45 CFR §164.530(j)) and other applicable retention rules.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Investigation Report

Healthcare Clinical Investigation Report

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL INVESTIGATION REPORT

Investigation Identification

Report ID: Date of Report:

Investigating Clinician / Reporter Affiliation / Department Contact Information

Patient Information

Patient Full Name

Date of Birth: Gender:

Address

Primary Phone

Email

Emergency Contact

Phone

Relationship

Insurance Information

Insurance Provider

Policy Number

Group Number

Subscriber Name

Medical History (Relevant)

Current Medications Allergies (including drug allergies) Prior Surgeries / Hospitalizations Chronic Conditions / Relevant Diagnoses

Study / Protocol Information

Study / Protocol Title

Sponsor / Sponsor Contact

Protocol / Study ID

IRB Approved: Yes No Site Name:

Event Details

Event Date: Event Time:

Location of Event Procedure / Activity at Time of Event Clinical Signs / Observations

Blood Pressure

Heart Rate

Resp. Rate

Temperature

O2 Saturation

Immediate Actions Taken

Investigation Findings

Summary of Findings Evidence Reviewed (records, images, device logs) Interviews Conducted Device / Medication Lot Numbers (if applicable)

Root Cause Analysis

Probable contributing factors (check all that apply):

Human error Device/equipment failure Medication error Protocol deviation Systemic/process issue Unknown

Root Cause Explanation

Corrective and Preventive Actions (CAPA)

Corrective Actions Planned / Implemented

Responsible Person / Team

Target Completion Date

Status: Implemented Pending Monitoring

Outcome and Follow-up

Severity: Serious Non-serious

Outcome Details

Hospitalization required: Yes No If admitted, Admission Date:

Attachments and Evidence

Lab reports Imaging Photographs Device logs Other

If Other, describe

Authorization and Privacy Acknowledgment

I hereby authorize the release and use of my protected health information as necessary to investigate the event described in this report. This authorization includes medical records, imaging, laboratory results, device logs, photographs, and any other information reasonably related to the investigation. Information may be shared with authorized clinical staff, the study sponsor, regulatory authorities, and institutional review or ethics committees solely for the purposes of investigation, remediation, and regulatory compliance.

I understand that I may revoke this authorization in writing at any time except to the extent that action has been taken in reliance on it. I understand that refusal to sign may limit the ability to conduct a full investigation, and that disclosures made pursuant to this authorization may be subject to re-disclosure by recipients and may no longer be protected by my local privacy protections to the extent permitted by law. I retain the right to withdraw this authorization, and withdrawal will not affect disclosures already made under this authorization prior to receipt of the revocation.

Authorization Expiration Date

I authorize release as stated above

I acknowledge I have been informed of privacy protections and rights

Certification: I certify that the information provided in this Clinical Investigation Report is true and complete to the best of my knowledge. I understand that intentional falsification of information may be subject to institutional disciplinary action and other legal penalties where applicable.

Patient Name:

Signature:

Date:

Relationship to Patient (if signing as guardian)

What a Healthcare Clinical Investigation Report Is

A Healthcare Clinical Investigation Report documents design, conduct, results, and safety findings from a clinical investigation, clinical trial, or observational study. It summarizes protocol objectives, population, intervention details, data collection methods, statistical analyses, and adverse events. The report supports regulatory review, institutional oversight (IRBs), sponsor monitoring, and publications while preserving an audit trail and reproducible records for compliance with HIPAA and applicable FDA recordkeeping standards such as 21 CFR Part 11 when cryptographic controls are required.

Why a clear, compliant report matters

A complete Healthcare Clinical Investigation Report creates a defensible record for patient safety, regulatory review, and institutional responsibility. It reduces ambiguity in adverse event follow-up, supports IRB and sponsor decisions, and helps meet legal and audit requirements under HIPAA and FDA records rules.

Who prepares and relies on these reports

Common users include clinical teams, institutional reviewers, and sponsors who need authoritative study documentation.

Principal investigators and clinical study staff: Draft, verify, and certify study methods, results, and safety narratives for oversight and regulatory review.
Institutional review boards and compliance officers: Use reports to evaluate risk, continuing review, and required corrective actions.
Sponsors and CROs: Aggregate findings for regulatory submissions, safety signal detection, and sponsor-level data reconciliations.

Accurate reporting speeds review cycles and reduces downstream requests for clarification from regulators, IRBs, and sponsors.

Step-by-step: preparing the report

Follow a consistent sequence to ensure completeness and traceability for reviewers and auditors.

01

Collect source data: Aggregate CRFs, lab reports, and monitoring notes.
02

Draft narrative: Summarize objectives, methods, and outcomes concisely.
03

Compile safety: List adverse events, severity, causality assessments.
04

Review and finalize: Obtain sign-offs from PI, sponsor, and quality control.

Security and compliance essentials

Encryption in transit: TLS 1.2/1.3

Encryption at rest: AES-256

Regulatory standards: HIPAA (BAA required)

Audit trail: Tamper-evident logs

21 CFR Part 11: Compliant options available

Access controls: Role-based permissions

Risks and consequences of incomplete or incorrect reports

Regulatory action: FDA warning or inspection

HIPAA breach fines: Civil monetary penalties

Research misconduct: Retraction or sanctions

Sponsor delays: Clinical hold or data rejection

Patient safety impact: Delayed corrective measures

Legal exposure: Litigation or liability

Common preparation and submission pitfalls

Incomplete adverse event descriptions that lack dates, severity, or causality impair safety assessment and trigger follow‑up queries.
Inconsistent identifiers — mismatched protocol or subject IDs — cause data linkage errors and audit findings.
Unsigned or improperly authenticated signatory blocks create uncertainty about attribution and can invalidate the report for regulatory use.
Missing or poorly formatted attachments (source data, redacted PHI) slow review and increase the risk of HIPAA noncompliance.

Essential components of a professional investigation report

A structured report organizes study context, methods, outcomes, safety data, and appendices so reviewers can rapidly assess validity and compliance.

Protocol summary

Concise objectives, design, and primary/secondary endpoints to orient reviewers and link outcomes to the study plan.

Methods

Population criteria, interventions, randomization, blinding, data collection instruments, and statistical analysis plans included in detail.

Results

Tabulated primary and secondary outcomes with confidence intervals, denominators, and handling of missing data documented.

Safety report

All adverse events, serious adverse events, causality assessments, and sponsor/PI responses organized chronologically and by severity.

Statistical analysis

Describe models, prespecified comparisons, interim analyses, and any deviations from the statistical analysis plan.

Appendices

Source data extracts, monitoring logs, consent forms, and ethics approvals provided as verifiable attachments.

How to configure a digital workflow for this report

Set fields, signer order, and authentication to match institutional and sponsor requirements before sending.

Field	Configuration
Signature block	Required; signer name and date
PI approval	Sequential signer after reviewer
Auth method	Email + SMS OTP or stronger
Attachments	PDF/A preferred; include audit log

Where to send the completed report

Route completed reports to institutional, sponsor, and regulatory recipients using secure channels and documented distribution lists.

Institutional archive: Submit to IRB or institutional records office per policy.
Sponsor submission: Deliver to sponsor or CRO in agreed format.
Regulatory filing: Provide to FDA or other regulators as required.
ClinicalTrials.gov: Post results where registration requires public disclosure.

Technical delivery and format considerations

Ensure the platform you use supports required formats, authentication levels, and secure storage for health data.

File formats: PDF/A, DOCX, or signed PDF
Integrations: EHR and document management supported
Authentication: Email, SMS OTP, or higher assurance

Choose systems that capture an auditable trail, provide robust access controls, and meet HIPAA and applicable FDA requirements for records and signatures.

Typical timelines and reporting expectations

Timelines depend on sponsor, IRB, and regulatory requirements; plan for rapid escalation paths for serious events and routine periodic reporting for study progress.

Serious adverse events:

Report immediately per sponsor and IRB guidance; follow FDA safety reporting rules.

Routine safety summaries:

Provide periodic cumulative safety reports as specified by protocol.

IRB continuing review:

Typically annual review or as required by the IRB.

Sponsor deadlines:

Adhere to contractually defined submission timelines.

Public results posting:

Follow ClinicalTrials.gov and journal timelines for disclosure.

Real-world examples of report use

Practical scenarios illustrate how reports support oversight and regulatory interactions.

Academic multi-center trial

A university PI consolidated site reports to summarize enrollment trends and safety signals

Data cleaning and central adjudication reduced variance
The compiled report enabled the IRB to approve a protocol amendment and accelerated sponsor review.

Device post-market study

A device sponsor used a standard report template to aggregate adverse events across sites

Rapid identification of a pattern triggered a product update
The traceable report supported discussions with FDA and limited patient risk while documentation was updated.

Best practices for efficient, auditable reports

Adopt standardized templates and controlled workflows to reduce errors and speed review.

Use consistent identifiers

Apply a single protocol and subject ID across all attachments to prevent reconciliation issues and audit findings.

Follow template structure

Standard sections reduce reviewer time and lower the risk of missing required content.

Record approvals electronically

Capture signer identity, timestamp, and authentication method for legal validity and auditing.

Retain source with report

Keep supporting CRFs, lab prints, and monitoring logs with the final report for verification.

eSignature vendor comparison for completing and signing reports

Compare common eSignature options for handling Healthcare Clinical Investigation Reports; signNow is listed first per comparison conventions.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	No	No	Yes, limited	Yes, limited
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions and troubleshooting

Answers to common questions about legality, signatures, and electronic submission for Healthcare Clinical Investigation Reports.

Need help? Contact support

Can this report be signed electronically?
Yes. Electronic signatures are generally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA in most states, provided intent, consent, attribution, and retention are satisfied.
When is a stronger authentication method required?
Use stronger authentication (SMS OTP, KBA, or vendor MFA) when PHI or regulatory risk is high, or when sponsor/IRB contractually requires elevated signer assurance.
Does HIPAA permit eSignature and cloud storage?
Yes, with safeguards. Covered entities must ensure vendor BAAs, encryption (TLS in transit, AES-256 at rest), access controls, and breach protocols are in place.
Are digital (PKI) signatures required?
Not always. PKI/digital signatures provide stronger non-repudiation and may be required by 21 CFR Part 11 for FDA-regulated electronic records.
How do I fix a post-signature error?
Prepare a signed amendment or corrected addendum, include rationale and approvals, and retain both original and correction with audit trail for transparency.
What records should be retained for audits?
Keep the final report, source documents, consent forms, audit logs, and signatory evidence. Follow HIPAA (45 CFR §164.530(j)) and other applicable retention rules.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now